D
endritic cells (DCs) bridge innate and adaptive immunity by acting as sentries that detect invading pathogens. In addition, they act as professional APCs capable of potently activating Ag-specific T cells (1, 2) . As a consequence of pathogen recognition, DCs undergo a program of maturation that includes Ag presentation by cell-surface MHC molecules and enhanced expression of essential costimulatory molecules including CD80 and CD86 (1) (2) (3) . In the steady state, immature DCs instead contribute to immune tolerance by presenting self-antigens to autoreactive lymphocytes, leading to their anergy, deletion, or conversion to induced regulatory T cells (4, 5) . DCs that become mature in the absence of infection can thus provoke an immune response to self Ags, as seen in autoimmune diseases from multiple sclerosis and type 1 diabetes to systemic lupus erythematosus (SLE) (6) . A role for DCs in human SLE pathogenesis is supported by the finding that DCs from SLE patients have been shown to upregulate CD86 expression independent of activating stimuli (7) .
Immature DCs use endocytic pathogen recognition receptors to detect infectious agents that bear pathogen-associated molecular patterns and, upon uptake and processing, present associated oligopeptides to T cells (8) . For example, DCs can detect viral dsRNA using retinoic acid-inducible gene I (RIG-I)-like receptors such as RIG-I (9, 10). Initiation of RIG-I signaling leads to the formation of a mitochondrial signaling complex consisting of MAVS, FADD, TRADD, TANK, and RIPK1, activation of IFN regulatory factors (IRFs) 3 and 7, and production of type I IFNs (IFN-I), cytokines with pleiotropic effects in immunity and disease (9, (11) (12) (13) (14) (15) . IFN-I constitute important antiviral cytokines and are a major stimulus for DC activation, but they are also considered a key driver of disease development in SLE (16, 17) .
The cysteine-aspartic acid protease, caspase-8 (CASP8), known for its canonical role in executing death receptor-mediated apoptosis, also inhibits necroptosis, an alternative form of programmed cell death that occurs under CASP8-deficient conditions (18, 19) . In many cell types, when CASP8 is inhibited, necroptosis can be triggered by the same stimuli that initiate apoptosis, such as death receptor ligation or TCR stimulation, and is mediated by the kinases RIPK1 and RIPK3 (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . However, Casp8 2/2 DCs are not more prone to dying upon treatment with the death receptor ligands TNF-a or FasL, suggesting that DCs lacking CASP8 are not sensitized toward necroptosis (31, 32) . In addition to its inhibitory effect on necroptosis, CASP8 is also a negative regulator of RIG-I signaling. CASP8 inhibits the formation of the RIG-I-dependent mitochondrial signaling complex by cleaving RIPK1, and a loss of CASP8 in nonhematopoietic cells resulted in enhanced phosphorylation of IRF3 (33) . CASP8 was also shown to directly cleave IRF3, leading to its degradation (34) . Subsequent studies showed that Casp8 ablation in DCs led to increased production of proinflammatory cytokines, due to a loss of inhibition of either RIPK3-mediated NLRP3 inflammasome activation, or RIPK1-and MyD88-mediated DC activation (31, 32) . Mice with Casp8 2/2 DCs were also shown to develop an agedependent autoimmune disease that was not prevented by deleting RIPK3, suggesting a non-necroptotic driver of this autoimmunity (32) . Indeed, DCs and macrophages appear to be unique in that a loss of Casp8 in these cell types does not appear to potentiate necroptosis, unlike in other tissues (26, (28) (29) (30) 35) . We chose to investigate the role of RIG-I signaling in disease development of these mice, as the overall contribution of the RIG-I pathway to the function of Casp8 2/2 DCs is unclear.
In this study we addressed the role of CASP8 in specific pathogen-free and disease conditions and, specifically, how the subtle modulation of one aspect of the innate immune response changes the balance between spontaneous autoimmune pathology and the efficacy of viral clearance. We show that mice with Casp8
2/2
DCs develop an age-dependent hyperactivation of DCs and T cells and associated immunopathology, with a predominance of IFN-gproducing Th1 cells. Along with age-dependent autoimmunity, the loss of Casp8 in DCs also allowed mice to mount an enhanced response to chronic viral infection, which was characterized by less exhausted, Ag-specific T cells and lower viral loads. These immunity characteristics correlated with DCs that were more sensitive to RIG-I stimulation in vitro. Thus, by regulating just one aspect of DC activation, CASP8 acts as a rheostat to dial in a well-tempered immune system, albeit one that is less efficacious.
Materials and Methods

Mice
Mice in which exon 3 of Casp8 is flanked by loxP sites (B6.129-Casp8tm1Hed) (backcrossed to C57BL/6J, n . 10) (36) were crossed to Cd11cCre mice [B6.Cg-Tg(Itgax-cre)1-1Reiz/J] (37) to generate Casp8 flox/flox Cd11cCre mice. These mice are referred to as dcCasp8
. SMARTA transgenic mice [TCR transgenes specific for H2-A b bound with lymphocytic choriomeningitis virus (LCMV) gp [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] ] (38) were a gift from A. Goldrath, University of California, San Diego. Animal work was performed according to University of California, San Diego guidelines.
Viral infections
Mice 6-10 wk old were infected i.v. via the retroorbital sinus with 2 3 10 6 PFU LCMV clone 13 (LCMV Cl13). Virus was grown, identified, quantified, and titered by plaque assay as previously described (39) . LCMV-specific ELISAs were performed as previously described (40) . 
Flow cytometry
In vitro stimulations
In total, 10 6 splenocytes were isolated and stimulated for 1 h with PMA (10 ng/ml) and ionomycin (1 mM) to assess CD4 T cell skewing, or LCMV peptides gp [33] [34] [35] [36] [37] [38] [39] [40] [41] (0.5 mM) or gp [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] (2 mg/ml) to assess cytokine production, after which monensin (eBioscience) was added for an additional 3.5 h, for a total stimulation of 4.5 h. + cells were stimulated for 16 h with anti-Fas, Jo2 clone (0.2 mg/ml; BD Biosciences) or short-length poly(I:C)-LyoVec at the indicated concentrations, with or without pretreatment for one hour with Necrostatin-1 (Nec-1) (30 mM; Enzo Life Sciences), and then stained with annexin V and propidium iodide (PI) (eBioscience), according to the manufacturer's instructions. For p-IRF3 analysis by flow cytometry, CD11c + cells were transfected with short-length poly(I:C)-LyoVec (5 mg/ml) for the indicated lengths of time. Poly(I:C)-LyoVec preparations and media used were endotoxin free.
Polyinosinic-polycytidylic acid transfections
Histopathology
Paraffin-embedded spleen and liver sections were stained with H&E. Splenic white and red pulp areas were quantified by ImageJ software (National Institutes of Health).
SMARTA adoptive transfer
LCMV-specific CD45.1 + CD45.2 + transgenic SMARTA CD4 + T cells were isolated by microbeads using negative selection to at least 85% purity (Miltenyi Biotec). Then, 5000 SMARTAs were transferred i.v. into recipient mice 1 d prior to LCMV Cl13 infection.
Bone marrow-derived DC differentiation
Bone marrow was harvested from femurs and tibias, resuspended in complete media containing 20 ng/ml each of GM-CSF and IL-4 (PeproTech), and placed in six-well plates at a density of 1 3 10 6 cells per ml. Two thirds of the media was replaced on days 3, 5, and 7 with fresh media plus GM-CSF and IL-4. Nonadherent cells were harvested on day 9, and negative selection with microbeads (Miltenyi Biotec) was used to remove F4/80 + , Ly6C + , and B220 + cells. Bone marrow-derived DCs (BMDCs) were then transfected for 0, 1, 2, or 4 h with short-length poly(I:C)-LyoVec and total cell lysates were isolated.
Immunoblot analysis
Equal amounts of protein from total BMDC lysates were resolved by 4-12% NU PAGE Bis-Tris gel (Invitrogen) and were transferred to Immobilon-P polyvinylidene difluoride membrane (Millipore) by semidry transfer (Bio-Rad). Blots were incubated overnight at 4˚C with primary Abs to p-IRF3 (Cell Signaling), total IRF3 (Cell Signaling) or LaminB (Santa Cruz), then incubated for 1 h at 25˚C with the appropriate HRP-conjugated secondary Ab. Bands were visualized by SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific).
Results
Mice with Casp8
2/2 DCs develop an age-dependent autoimmune phenotype
To investigate the contribution of CASP8 in the regulation of DCs, mice with a Casp8 flox/flox allele were crossed with Cd11cCre mice to generate Casp8
Cd11cCre conditional knockout mice (hereafter referred to as dcCasp8 2/2 mice). Deletion of exon 3 of Casp8 in CD11c + splenocytes from dcCasp8 2/2 mice was validated by PCR (Fig. 1A ). These mice displayed higher proportions of hyperactive CD11b + and CD8 + cDCs at 3 mo of age, as assessed by the expression of CD86 (Fig. 1B) , and cDCs from dcCasp8 2/2 mice remained hyperactive through 14-plus mo of age. To determine whether the hyperactivation seen in cDCs was reflected in the population of T cells, we assessed the status of T cells by enumerating previously activated (CD44 + T cells from dcCasp8 2/2 mice generated increased proportions of activated T cells at 3 mo of age, whereas activated CD8 + T cells were not increased until 6 mo of age (Fig. 1C) . The proportion of previously activated T cells in control (Casp8 flox/flox ) mice increased with age; however, this was substantially accelerated in dcCasp8 2/2 mice for both CD4 + and CD8 + subsets. We next determined whether the hyperactive cDCs and T cells in aged dcCasp8 2/2 mice had an effect on organ immunopathology. Spleens from aged dcCasp8 2/2 mice displayed a disrupted splenic architecture, as demonstrated by an expansion of white pulp (Fig. 1D ). Livers from aged dcCasp8 2/2 mice showed an increase in polymorphic infiltrates similar to the infiltrating leukocytes seen in autoimmune mice with Fas-deficient cDCs (41) (Fig. 1D ). Because aged dcCasp8 2/2 mice appeared to display signs of autoimmunity, we examined whether the number of Foxp3 + regulatory T cells was diminished. On the contrary, we found increased percentages and numbers of Foxp3 + regulatory T cells in 10 mo old dcCasp8 2/2 mice (Fig. 1E ). 
CD4
+ T cells from aged dcCasp8 2/2 mice skew toward a Th1 phenotype Many autoimmune diseases are characterized by the emergence of a particular CD4 + Th subset characterized by its hallmark cytokine. For example, IFN-g-producing Th1 cells are more prevalent in the peripheral blood of human SLE patients (42) . To determine whether CD4 + T cells in aged dcCasp8 2/2 mice were polarized for a specific Th subset, we stimulated splenocytes in vitro with PMA and ionomycin for 4 h and analyzed the appearance of diagnostic cytokines. The results showed an increased subset of CD4 + T cells from aged dcCasp8 2/2 mice that produced IFN-g, when compared with control mice, whereas the proportions of CD4 + T cells producing IL-4 and IL-17 were similar (Fig. 2) .
Young adult dcCasp8 2/2 mice mount an enhanced Ag-specific T cell response to chronic viral infection Because specific pathogen-free dcCasp8 2/2 mice display accelerated development of activated cDCs and T cells over time, we determined how dcCasp8 2/2 mice would respond to a viral infection. Taking into account our observation that dcCasp8 2/2 mice developed a detectable increase in activated cDCs and CD4 + T cells by 3 mo of age, we infected young adult (6-10 wk old) mice before the appearance of phenotypic manifestations of the Casp8 deletion. Specifically, we wished to determine whether dcCasp8 2/2 mice would mount an exaggerated response to viral infection as a result of enhanced cDC activation and Ag presentation to T cells.
LCMV is an RNA virus that is detected by RIG-I (43). Inoculation of C57BL/6 mice with 10 6 PFU LCMV Cl13, the chronic form of LCMV, results in a long and persistent viral infection (39, 44) . A characteristic of the CD4 + and CD8 + T cell response is the induction of multiple negative feedback pathways starting day 12 postinfection (p.i.), and these mechanisms appear to prolong the viral infection while lessening the associated immunopathology (45, 46) . Previous work has shown that removal of negative regulation can be readily detected (47, 48) . In addition, LCMV Cl13 is able to establish a chronic infection partly because it selectively infects and suppresses DCs (49) , and thus, enhanced DC function might be expected to mitigate this form of LCMV virulence.
Upon infection of 6-10 wk old dcCasp8 2/2 mice with LCMV Cl13, the expansion of Ag-specific T cell responses was examined using tetramers specific for the major immunodominant CD4 + and CD8 + T cell epitopes. We found that dcCasp8 2/2 mice had higher proportions of H2-A b gp66 + CD4 + T cells at days 8 and 15 p.i. (Fig. 3A) (Fig. 3A) . Overall, dcCasp8 2/2 mice possessed substantially higher frequencies of gp66-specific CD4 + T cells compared with control mice early in the infection, and this would be predicted to have an important effect on the expansion of CD8 + T cells and the clearance of virus.
T cells from chronically infected dcCasp8 2/2 mice retain effector function T cells achieve their antiviral effector function, in part, by producing cytokines such as IFN-g and TNF. We assessed the ability of T cells from LCMV Cl13-infected dcCasp8 2/2 mice to produce IFN-g and TNF upon restimulation with either CD4 + or CD8 + T cell LCMV-specific peptides (gp [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] and gp [33] [34] [35] [36] [37] [38] [39] [40] [41] , respectively). The results showed that, consistent with the increased frequency of LCMV-specific T cells, a higher proportion of CD4 + T cells from dcCasp8 2/2 mice were polyfunctional and produced both IFN-g and TNF at days 8 and 15 p.i. (Fig. 3B) , and a higher proportion of CD8 + T cells from dcCasp8 2/2 mice were polyfunctional and produced both IFN-g and TNF at days 15 and 30 p.i. (Fig. 3C) . Taken together, these results suggest that chronically infected dcCasp8 2/2 mice have an early (days 8-15 p.i.) enhancement in the CD4 + T cell response, and a late (days 15-30 p.i.) enhancement in the CD8 + T cell response.
The effect of DC-specific Casp8 deletion on T cell exhaustion and viral clearance
Because we had seen more effector CD4 + and CD8 + T cells from dcCasp8 2/2 mice compared with control mice, we investigated whether T cells from dcCasp8 2/2 mice expressed differential levels of the inhibitory receptor PD-1, which is upregulated during T cell exhaustion (45) . Analysis showed that H2-A b gp66 + CD4 + T cells from dcCasp8 2/2 mice expressed lower amounts of PD-1 by both median fluorescence intensity and the percentage of PD-1 hi expressing cells at day 30 p.i. (Fig. 4A) . Similar results were found analyzing H2-D b gp33 + CD8 + T cells from dcCasp8 2/2 mice. Because dcCasp8 2/2 mice possessed T cells that retained the ability to produce antiviral cytokines and were less exhausted at day 30 p.i., there was a possibility that virus load would be correspondingly reduced. Consistent with the time-course of T cell expansion and effector function, dcCasp8 2/2 mice displayed lower viral loads in serum, liver, and kidney at day 30 p.i. as measured by plaque assay (Fig. 4B, 4C) . (Fig. 4D) . Unexpectedly, we found that dcCasp8 2/2 mice had substantially fewer germinal center (GC) B cells as measured by the expression of GL-7 and Fas (53) (Fig. 4E) (54) . Additionally, at day 30 p.i. dcCasp8 2/2 mice had higher levels of LCMV-specific IgG2a Ab, which is the isotype preferentially driven by increased IFN-g (55) . No differences in the amounts of LCMV-specific total IgG or IgG1 Abs were found (Fig. 4F) .
The discrepancy between increased numbers of Tfh cells, increased Abs, but reduced GC B cells has not been resolved. Although the increased frequency of plasmablasts and plasma cells in dcCasp8 2/2 mice was not statistically significant, it could help explain why dcCasp8 2/2 mice have increased Tfh cells and increased LCMV-specific Abs. A chronic viral infection could accelerate the disruption of splenic architecture observed in uninfected aged dcCasp8 2/2 mice (Fig. 1D ), leading to a loss of splenic structure required for GC B cell formation. For example, although Lupus-prone MRL.Fas lpr mice spontaneously develop GCs, they are lost over time and are no longer detectable in 6 mo old mice, perhaps due to the collapse of splenic architecture (56) .
LCMV-specific CD4 T cells from chronically infected dcCasp8
2/2 mice have enhanced expansion and effector function To address the possibility that pre-existing hyperactivated CD4 + T cells in dcCasp8 2/2 mice contribute to the larger proportion of either H2-A b gp66 + CD4 + T cells or IFN-g/TNF-producing CD4 + T cells in these mice (Fig. 3A, 3B ), we adoptively transferred CD4 + T cells from SMARTA transgenic mice into control and dcCasp8 2/2 recipients followed by infection with LCMV Cl13. SMARTA mice have CD4 + T cells specific for the gp 61-80 epitope of LCMV (38) . We found that CD45.1 + CD45.2 + SMARTA CD4 + T cells transferred into dcCasp8 2/2 hosts expanded to a greater degree in the blood at day 5 p.i. (Fig. 5A) , and in the spleen at day 8 p.i. (Fig. 5B) . When we examined the ability of SMARTA CD4 + T cells from dcCasp8 2/2 hosts to produce effector cytokines upon restimulation with the CD4 + T cell LCMV-specific peptide (gp 61-80 ), we found that a higher proportion of SMARTA CD4 + T cells from dcCasp8 2/2 mice produced either IFN-g alone, both IFN-g and TNF, or both IFN-g and IL-2, a finding consistent with the enhanced expansion of these cells in dcCasp8 2/2 hosts (Fig. 5C ). These results show that dcCasp8 2/2 mice promote an enhanced expansion of naive T cells.
RIG-I stimulation hyperactivates cDCs lacking Casp8
We hypothesized that, in dcCasp8 2/2 mice, both the agedependent autoimmune phenotype and the enhanced response to chronic infection resulted from the loss of negative regulation of RIG-I signaling by CASP8 in cDCs. To directly test this, we activated RIG-I in Casp8 2/2 cDCs by transfecting them with short-length poly (I:C), which is a surrogate for dsRNA and is specifically detected by RIG-I (57). We isolated splenic CD11c + cells from control and dcCasp8 2/2 mice and transfected them with increasing doses of poly (I:C), then assessed the upregulation of the costimulation molecule CD86. We found that both CD11b + and CD8 + cDCs upregulated CD86 to a greater degree than control cDCs in a poly(I:C) dosedependent manner (Fig. 6A) .
To determine whether Casp8 2/2 cDCs hyperactivate due to a cell-intrinsic or cell-extrinsic mechanism, we cocultured Casp8 (Fig. 6B ). To directly assess whether this cell-extrinsic effect could be the result of Casp8 2/2 cDCs producing more IFN-I upon RIG-I stimulation, we measured levels of IFN-b in the supernatant of poly(I:C)-transfected CD11c + cells. Surprisingly, we found that the supernatant of Casp8 2/2 CD11c + cells contained significantly higher levels of IFN-b at only one concentration of transfected poly(I:C) compared with control supernatant (Fig. 6C) . However, when we assessed the levels of several other proinflammatory cytokines, IFN-g, TNF-a, IL-6, and MCP-1 were all found to be upregulated in the supernatant of Casp8 2/2 CD11c + cells in response to increasing doses of transfected poly(I:C) (Fig. 6C) , consistent with the cell-extrinsic DC hyperactivation mechanism predicted by Fig. 6B .
cDCs lacking Casp8 are not sensitized to necroptosis
Loss of Casp8 in a variety of cell types leads to necroptosis, an alternative mode of programmed cell death that occurs when a cell receives death stimuli in the face of apoptosis inhibition (24, 25, 28) . Immature DCs become mature upon coculture with cells undergoing necrosis or exposure to necrotic cell supernatant, likely due to the release of danger-associated molecular patterns during necrosis, but they do not mature when cultured with apoptotic cells or apoptotic cell supernatant (58) .
To investigate whether necroptosis of Casp8 2/2 cDCs could contribute to the hyperactivation of these cells, we first used a membrane permeable dye to compare levels of total cell death in control and Casp8 2/2 poly(I:C)-transfected CD11c + cells, and found that the numbers of live control or Casp8 2/2 cDCs per well were comparable (Fig. 6D) by Fas signaling yet was not inhibited by the addition of Nec-1, an inhibitor of RIPK1. Thus, Casp8 2/2 cDCs do not appear to undergo necroptosis when death receptor signaling is triggered, consistent with a previous report (32) .
BMDCs lacking Casp8 have enhanced IRF3 activation upon RIG-I stimulation
We originally predicted that the hyperactivation phenotype of Casp8 2/2 DCs was due to a loss of negative regulation of IRF3.
Thus, we measured whether levels of p-IRF3 in poly(I:C)-transfected Casp8 2/2 DCs were higher. Casp8 2/2 BMDCs transfected with poly(I:C) showed enhanced p-IRF3 expression at 4 h compared with control BMDCs, whereas levels of total IRF3 and LaminB were similar between Casp8 2/2 and control BMDCs at 4 h (Fig. 7A) .
To test whether splenic Casp8 2/2 cDCs also had enhanced p-IRF3 expression upon RIG-I stimulation, we analyzed levels of p-IRF3 in poly(I:C)-transfected CD11c + cells by flow cytometry. We found that whereas levels of p-IRF3 were not notably higher in either unstimulated (0 h) or RIG-I stimulated (4 h) CD11b +
Casp8
2/2 cDCs, p-IRF3 levels were higher in a subset of CD11b + cDCs, which were also CD86 + , under both conditions (Fig. 7B) . We infer that the CD11b + CD86 + cDCs are the DCs that are either endogenously activated (0 h) or become activated after RIG-I stimulation (4 h). Thus, it appears that both Casp8 2/2 BMDCs and the activated subset of Casp8 2/2 splenic cDCs upregulate P-IRF3 to a greater degree compared with controls.
Of note, control and Casp8 2/2 CD8 + splenic cDCs expressed similar levels of p-IRF3, regardless of whether they were transfected with poly(I:C) (data not shown). One explanation is the very low expression of RIG-I in CD8 + DCs and the lack of IFN-a production by this DC subset in response to infection with two RNA viruses, Sendai virus, or influenza A virus (59), indicating that CD8 + DCs do not use RIG-I to detect viral RNA.
Discussion
Although DCs represent a small proportion of total immune cells, they are essential for both initiating and preventing adaptive immune responses. These seemingly paradoxical outcomes depend in large part on whether the DCs are activated. Immature, unactivated DCs help prevent autoimmunity by presenting self-antigens to selfreactive T cells that have escaped thymic deletion, and such T cells are either deleted or become anergic (60) . If mature DCs present oligopeptides to T cells, the result is T cell activation and proliferation such that in principle, presentation of a self-peptide by a mature DC could result in an autoimmune response (6) . The fact that T cells require activated, mature DCs (induced through exposure to adjuvant or by pathogen-recognition receptor signaling) constitutes the basis for "the immunologist's dirty little secret" as presciently described by Janeway (61) . A surprising aspect of the present work is that CASP8 exerts a quantitatively modest effect on the activation status and cytokine production of DCs, and yet, Casp8 deletion in DCs is sufficient to push the immune system into a state of self-reactivity as well as affect the progression of a persistent viral infection. This highlights the notion that immune regulation balances on a knife-edge between self-reactivity and effective immunity. As it is presently evolved, there appears to be little margin for the further enhanced effectiveness of adaptive immunity.
The importance of DCs in mediating self-tolerance is illustrated in mouse models of constitutive DC ablation. CD11c-DTA mice, which primarily lack DCs (but also certain macrophages, NK cells, and activated T cells), display impaired CD4 + and CD8 + T cell responses, and in one study they developed steady-state autoimmunity characterized by CD4 + T cell activation (62) . When DCs are constitutively deleted from lupus-prone MRL.Fas lpr mice, agedependent T cell expansion and differentiation into IFN-g-producing effector cells was diminished, leading to disease reduction (63) . However, when activated DCs are unable to be eliminated via Fasmediated killing, systemic autoimmunity developed (41) .
Several genes have been identified as negative regulators of DC activation; for example, mice with DC-specific ablations of A20 or SHP1 spontaneously developed mature DCs that produced more inflammatory cytokines and drove the increased activation and differentiation of T cells (6) . The effect of deleting a DC-negative regulator on the viral immune response in vivo is less clear. CASP8 is a negative regulator of RIG-I signaling, a key pathway for detection of RNA viruses in DCs (10, 33) . Mice with a DCspecific ablation of Casp8 have previously been shown to develop an age-dependent autoimmunity that depends on TLR signaling (32) . We show in this study that stimulated CD4 + T cells from aged dcCasp8 2/2 mice skew toward a Th1 phenotype, indicating a possible role for IFN-g in disease pathogenesis. We further explored the consequences of hyperactive DCs in the context of a chronic viral infection. These experiments revealed an adjuvantlike effect with the loss of Casp8 in DCs, as dcCasp8 2/2 mice have an enhanced immune response to LCMV Cl13, an RNA virus detected by RIG-I. The observation that hyperactive DCs can aid in the resolution of chronic viral infection, despite their damaging role in driving steady-state autoimmunity, is consistent with the finding that although mice with Fas-deficient DCs develop systemic autoimmunity, they also clear a chronic LCMV infection more rapidly (41, 64) .
Over time, dcCasp8 2/2 mice develop systemic autoimmunity in the absence of external pathogen challenge. This suggests that peripheral tolerance depends upon the precise regulation of DC activation, and self-tolerance is lost with even a modest imbalance in innate signaling. dcCasp8 2/2 mice would be expected to display enhanced Ag presentation to naive T cells, and this was borne out in experiments in which LCMV-specific CD4 T cells (SMARTA) were transferred into either control or dcCasp8 2/2 mice. This finding supports the idea that the enhanced early CD4 + T cell response in LCMV Cl13 infected dcCasp8 2/2 mice is likely due to the superefficient cDCs and not pre-existing hyperactivated T cells. In contrast, the enhanced CD8 + T cell response found later (days 15 and 30 p.i.) may or may not result from Casp8-deficient DCs. Given that a greater proportion of Ag-specific CD4 + T cells in dcCasp8 2/2 mice are polyfunctional, one possibility is that the CD8 + T cells in infected dcCasp8 2/2 mice receive more help from CD4 + T cells (50, 52) . We predicted that Casp8-deficient cDCs are hypersensitive to RIG-I stimulation, and we found that Casp8 2/2 cDCs upregulated CD86 to a greater degree than control cDCs upon transfection with poly(I:C). We also predicted that a loss of Casp8 in cDCs would lead to hyperactive IRF3 and increased IFN-I production, and although the increase in IFN-b secretion by RIG-I stimulated Casp8 2/2 cDCs was only significant at a single concentration of transfected poly(I:C) (Fig. 6C) , we found that Casp8 2/2 BMDCs had enhanced IRF3 activation as measured by p-IRF3 (Fig. 7A ). Exposure to IFN-I not only leads to DC activation, including upregulation of costimulatory molecules such as CD86 and CD80, but has also been shown to increase IFN-g and TNF-a production by DCs (65) (66) (67) (68) . Thus, the enhanced activation of IRF3 in poly(I:C)-transfected Casp8 2/2 DCs appears to lead to slightly higher levels of IFN-b production, which could act in an autocrine fashion on DCs to promote proinflammatory cytokine production and T cell stimulation.
If enhanced IRF3 activation in Casp8 2/2 cDCs was responsible for the observed DC hyperactivation, we might expect that deleting IRF3 in dcCasp8 2/2 mice would ameliorate this phenotype. Perhaps surprisingly, one group found that IRF3 2/2 dcCasp8 2/2 mice instead had exacerbated lymphoproliferation compared with dcCasp8 2/2 mice (32). However, the IRF3 2/2 dcCasp8 2/2 mice analyzed in this study had a germline deletion of IRF3, indicating that the contributions of IRF3-deficient non-DCs to accelerating lymphoproliferation cannot be ruled out.
Unlike in many other cell types, Casp8 deficiency in DCs does not appear to potentiate necroptosis. CASP8 is needed to both prevent necroptosis of proliferating T cells during the initiation of an adaptive immune response, as well as trigger apoptosis of T cells during the contraction of the response (27, 28, 69) . However, RIG-I-stimulated control and Casp8 2/2 cDCs underwent comparable levels of annexin V + PI + cell death regardless of whether Nec-1 was added, indicating a RIPK1-independent root cause of the phenotypes observed in dcCasp8 2/2 mice. Additionally, although we found that Casp8 2/2 cDCs secreted increased amounts of IL-1b upon LPS treatment, consistent with two previous studies (31, 32) , there was no difference in IL-1b production from poly(I:C)-transfected cDCs. We conclude that our findings are consistent with studies showing that deletion of Casp8 in DCs leads to hyperactivation of downstream elements (31) (32) (33) (34) . In addition, this hyperactivation would appear to be RIPK1 and IL-1b independent.
Finally, we found that mice with hyperactive DCs lacking Casp8 have delayed T cell exhaustion during chronic LCMV infection, indicating a possible therapeutic application for these DCs. T cell exhaustion is characterized by a loss of effector cytokine production and upregulation of inhibitory receptors such as PD-1 and CTLA-4, and it plays a major role in disease progression of many chronic infections and cancer (45, 46) . Given the role of therapeutic checkpoint inhibitors that block these T cell inhibitory pathways to enhance antitumor immunity, we speculate that enhancing DC function, even modestly, could have a major impact on the course of an immune response.
